Galderma Study Site — Chestnut Hill, Massachusetts

Galderma Study Site is a clinical research site located in Chestnut Hill, Massachusetts, United States 02467.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Galderma Study Site has participated in 1 clinical trials.

Therapeutic areas: Cheek Augmentation.

Sponsors: Galderma R&D.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chestnut Hill

Browse all research sites in Massachusetts · View every site in Chestnut Hill

• Brigham and Women's Hospital
• Osher Clinical Center at Brigham and Women's Hospital
• Brigham & Women's Hospital
• Brigham and Women's Hospital Pain Trials Center
• Harvard Vanguard / New England Baptist Hospital
• Brigham and Women's Hospital Pain Management Center
• Brigham and Womens Hospital
• Brigham & Women's Hospital Women's Health Center
• Brigham and Women's Hospital - Harvard University
• Cartilage Repair Center, Brigham and Women's Hospital
• SkinCare Physicians
• Skin Care Physicians

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Galderma Study Site?

Galderma Study Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Galderma Study Site conducted?

Galderma Study Site has 1 clinical trials on record. Their work covers Cheek Augmentation.

Is Galderma Study Site accredited by Crixeo Clinical Trials?

Galderma Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Galderma Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.